108 related articles for article (PubMed ID: 2860764)
1. [Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)].
Raevskiĭ KS; Aleksandrovskiĭ IuA; Poiurovskiĭ MV; Kharlamov AN; Neznamov GG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):574-9. PubMed ID: 2860764
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
Aleksandrovskiĭ IuA; Ben'kovich BI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
[TBL] [Abstract][Full Text] [Related]
3. [Role of the GABA-ergic link in the development of the tranquilizing effect in cats].
Kozlovskaia MM; Kharlamov AN; Raevskiĭ KS; Val'dman AV
Biull Eksp Biol Med; 1981; 91(1):45-8. PubMed ID: 6111364
[TBL] [Abstract][Full Text] [Related]
4. [New evidence for a GABA-ergic component in the mechanism of action of benzodiazepine tranquilizers].
Zakusov VV; Ostrovskaia RU
Biull Eksp Biol Med; 1981 May; 91(5):571-4. PubMed ID: 6789910
[TBL] [Abstract][Full Text] [Related]
5. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.
Dombrowski PA; Fernandes LH; Andreatini R
Eur J Pharmacol; 2006 May; 537(1-3):72-6. PubMed ID: 16626689
[TBL] [Abstract][Full Text] [Related]
6. [Implications of GABAergic synapses in neuropsychiatry].
Lloyd KG; Perrault G; Zivkovic B
J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
[TBL] [Abstract][Full Text] [Related]
7. [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics].
Vasil'ev AA; Nuller IuL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1217-22. PubMed ID: 2877531
[TBL] [Abstract][Full Text] [Related]
8. [Psychophysiologic characteristics of the individual psychotropic activity of benzodiazepine derivatives under experimental conditions].
Val'dman AV; Kozlovskaia MM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(6):911-9. PubMed ID: 27927
[TBL] [Abstract][Full Text] [Related]
9. On a possible role of GABA in mania. Therapeutic efficacy of sodium valproate.
Emrich HM; von Zerssen D; Kissling W; Möller HJ
Adv Biochem Psychopharmacol; 1981; 26():287-96. PubMed ID: 6779508
[No Abstract] [Full Text] [Related]
10. Enhancement of GABAergic inhibition: a mechanism of action of benzodiazepines, phenobarbital, valproate and L-cycloserine in the cat spinal cord.
Polc P
Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():188-98. PubMed ID: 6130936
[TBL] [Abstract][Full Text] [Related]
11. [New problems in GABAergic pharmacology of anxiety].
Kaluev AV
Eksp Klin Farmakol; 1997; 60(5):3-7. PubMed ID: 9483395
[TBL] [Abstract][Full Text] [Related]
12. The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide.
Vellucci SV; Webster RA
Pharmacol Biochem Behav; 1984 Dec; 21(6):845-51. PubMed ID: 6151667
[TBL] [Abstract][Full Text] [Related]
13. [Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
Voronina TA; Garibova TL
Biull Eksp Biol Med; 1980 Jul; 89(7):41-3. PubMed ID: 6773598
[TBL] [Abstract][Full Text] [Related]
14. [Use of diazepam in psychiatric practice].
Aleksandrovskiĭ IuA; Prokudin VN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1231-7. PubMed ID: 5705720
[No Abstract] [Full Text] [Related]
15. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety].
Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783
[TBL] [Abstract][Full Text] [Related]
16. Does sodium valproate increase clinical effects of diazepam? Double blind study.
Vinar O; Dvorák A; Vinarová E; Fácková M; Pavlícek N; Tosnerová T; Husovská G
Act Nerv Super (Praha); 1989 Jun; 31(2):106-7. PubMed ID: 2572129
[No Abstract] [Full Text] [Related]
17. [Effect of GABA-negative preparations on the anxiolytic and sedative effects of diazepam].
Andreev BV; Ignatov IuD
Biull Eksp Biol Med; 1981 Jun; 91(6):685-7. PubMed ID: 6115689
[TBL] [Abstract][Full Text] [Related]
18. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
[TBL] [Abstract][Full Text] [Related]
19. [Open clinical testing of 7-chlor-1-(cyclopropylmethyl)-1, 3-dihydro-5 phenyl-2H-1, 4 benzodiazepine-2-one(Prazepam) in the indication as tranquilizing and antispastic agent].
Bruck J; Tshabitscher H
Nervenarzt; 1973 Oct; 44(10):547-9. PubMed ID: 4587871
[No Abstract] [Full Text] [Related]
20. [Experience in using fenazepam to treat psychotic patients].
Nuller IuL; Tochilov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):914-20. PubMed ID: 6106340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
